IRIDEX Corporation (IRIX)
-NasdaqGM | Prev Close: | 6.50 |
|---|
| Open: | N/A |
|---|
| Bid: | 6.40 x 400 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 5.00 |
|---|
| Beta: | 0.78 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 3.07 - 6.57 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 18,252 |
|---|
| Market Cap: | 55.69M |
|---|
| P/E (ttm): | 83.33 |
|---|
| EPS (ttm): | 0.08 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Ophthalmology Innovators: Will InSite Follow Recent Successes?at Seeking Alpha(Thu, May 16)
- IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business UnitPR Newswire(Thu, May 16)
- IRIDEX CORP FinancialsEDGAR Online Financials(Sat, May 11)
- IRIDEX CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 6)
- IRIDEX's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 3)
- IRIDEX Earnings Call scheduled for 5:00 pm ET todayCCBN(Thu, May 2)
- IRIDEX Reports 2013 First Quarter ResultsPR Newswire(Thu, May 2)
- IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, May 2)
- Q1 2013 IRIDEX Earnings Release - After Market CloseCCBN(Thu, May 2)
- IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing CountriesPR Newswire(Tue, Apr 30)
- IRIDEX Announces First Quarter 2013 Conference Call and Release DatePR Newswire(Thu, Apr 25)
- 4 Healthcare Stock Stories for Wednesday Investment Wellnessat Wall St. Cheat Sheet(Wed, Apr 3)
- IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd.PR Newswire(Tue, Apr 2)
- IRIDEX CORP Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 28)
- IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Wed, Mar 27)
Key Statistics
| Forward P/E (1 yr): | 20.31 |
|---|
| P/S (ttm): | 1.61 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.22 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.04 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | 2.92 |
|---|
Business Summary
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology worldwide.
View More